# RELMADA THERAPEUTICS, INC. — Form D

RELMADA THERAPEUTICS, INC. of NEW YORK, NY, a company, filed a Form D exempt-offering notice with the SEC on 2019-06-27. The offering totals $10.0M, of which $8.0M was reported sold. Industry: Biotechnology.

## Offering

- Filed: 2019-06-27
- Form: D
- Accession: 0001213900-19-011648
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $10.0M
- Amount sold: $8.0M
- Remaining: $2.0M
- Minimum investment: $10K
- Investors: 108
- Date of first sale: 2019-06-14
- Security types: equity
- Revenue range: No Revenues
- SEC file number: 021-343016

## Issuer

- Name: RELMADA THERAPEUTICS, INC.
- CIK: 0001553643
- Entity type: Corporation
- Jurisdiction: NEVADA
- Incorporated: 2012
- Address: 880 3RD AVENUE, 12TH FLOOR, NEW YORK, NY, 10022
- Phone: 646 876 3459

## Officers, directors & promoters (12)

| Name | Role | Location |
| --- | --- | --- |
| Charles Casamento | Director | SAN FRANCISCO, CA |
| Paul Kelly | Director | Boston, MA |
| Sergio Traversa | Director | Blue Bell, PA |
| Sergio Traversa | Executive Officer | Blue Bell, PA |
| Maged Shenouda | Director | New York, NY |
| Ottavio Vitolo | Executive Officer | New York, NY |
| Chuck Ence | Executive Officer | New York, NY |
| Nabil M Yazgi | Director | NEW YORK, NY |
| Douglas O Beck | Executive Officer | NEW YORK, NY |
| Shreeram O Agharkar | Director | NEW YORK, NY |
| Sandesh O Seth | Director | NEW YORK, NY |
| Eliseo O Salinas | Executive Officer | NEW YORK, NY |

## Other filings by this issuer (9)

| Filed | Form | Offering | Sold |
| --- | --- | --- | --- |
| [2019-10-08](https://search.stillhousedata.com/formd/0001213900-19-019994) | D | $826K | $826K |
| [2019-07-10](https://search.stillhousedata.com/formd/0001213900-19-012436) | D/A | $10.0M | $8.4M |
| [2019-05-16](https://search.stillhousedata.com/formd/0001213900-19-009006) | D | $10.0M | $3.4M |
| [2018-12-10](https://search.stillhousedata.com/formd/0001213900-18-017157) | D/A | $10.0M | $5.8M |
| [2018-11-13](https://search.stillhousedata.com/formd/0001213900-18-015444) | D/A | $10.0M | $4.6M |
| [2018-10-22](https://search.stillhousedata.com/formd/0001213900-18-014204) | D | $10.0M | $3.3M |
| [2017-10-06](https://search.stillhousedata.com/formd/0001213900-17-010345) | D | $6.9M | $6.9M |
| [2014-06-19](https://search.stillhousedata.com/formd/0001213900-14-004304) | D | $10.7M | $10.7M |
| [2014-06-04](https://search.stillhousedata.com/formd/0001213900-14-003956) | D | — | — |

## More

- [CIK 1553643 on SEC EDGAR (source of record)](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=1553643&type=&dateb=&owner=include&count=40)
- [This page as markdown (for LLM agents)](https://search.stillhousedata.com/formd/0001213900-19-011648.md)
- [Search all SEC filings, advisers and people on Adviser Search](https://search.stillhousedata.com/)

---

Source: public SEC filing data via Adviser Search (https://search.stillhousedata.com).
Agents: this data is also queryable via MCP tools and read-only SQL — see https://search.stillhousedata.com/llms.txt.